We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

17 hedge funds and large institutions have $11.9M invested in Virtus Biotech ETF in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

23% more capital invested

Capital invested by funds: $9.68M → $11.9M (+$2.19M)

13% more funds holding

Funds holding: 15 → 17 (+2)

3.49% more ownership

Funds ownership: 38.51% → 42% (+3.5%)

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$1.11M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$200K
3
SMG
Smart Money Group
Texas
+$46K
4
Bank of America
Bank of America
North Carolina
+$3.41K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.07M
2
UBS Group
UBS Group
Switzerland
-$70.8K
3
FAIM
Financial Advocates Investment Management
Washington
-$48.2K
4
Stifel Financial
Stifel Financial
Missouri
-$33.2K
5
PMFA
Plante Moran Financial Advisors
Michigan
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$4.79M -$1.07M -26,720 -20%
SMG
2
Smart Money Group
Texas
$2.7M +$46K +1,145 +2%
Jane Street
3
Jane Street
New York
$1.67M +$1.11M +27,572 +256%
Citadel Advisors
4
Citadel Advisors
Florida
$541K -$723 -18 -0.1%
FAIM
5
Financial Advocates Investment Management
Washington
$507K -$48.2K -1,200 -9%
LPL Financial
6
LPL Financial
California
$436K -$1.04K -26 -0.3%
AWCI
7
Alpine Woods Capital Investors
New York
$370K – – –
Stifel Financial
8
Stifel Financial
Missouri
$326K -$33.2K -826 -10%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$217K +$200K +4,989 New
Morgan Stanley
10
Morgan Stanley
New York
$80K -$11.5K -287 -13%
RWB
11
RMR Wealth Builders
New Jersey
$65K +$60.2K +1,499 New
UBS Group
12
UBS Group
Switzerland
$63K -$70.8K -1,764 -55%
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$57K -$6.83K -170 -12%
FWM
14
Focused Wealth Management
New York
$30K – – –
CFA
15
Carroll Financial Associates
North Carolina
$11K – – –
Bank of America
16
Bank of America
North Carolina
$4K +$3.41K +85 New
CFB
17
Cullen/Frost Bankers
Texas
$3K – – –
PMFA
18
Plante Moran Financial Advisors
Michigan
– -$30K -846 Closed

BBP Hedge Fund Activity: Q4 2019 in Review

17 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2019, worth a combined $11.9M — up 23% from $9.68M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BBP positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 8 trimmed.

The largest buyer was Jane Street, adding an estimated $1.11M. The largest seller was Royal Bank of Canada, cutting an estimated $1.07M.

  • 17 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2019, up from 15 in Q3 2019.
  • Funds reported $11.9M of Virtus Biotech ETF stock for Q4 2019, up 23% quarter-over-quarter.
  • 3 funds opened new Virtus Biotech ETF positions in Q4 2019 and 1 closed out, a net change of +2 holders.
  • The largest Virtus Biotech ETF buyer in Q4 2019 was Jane Street, an estimated $1.11M added.
  • The largest Virtus Biotech ETF seller in Q4 2019 was Royal Bank of Canada, an estimated $1.07M sold.

Based on aggregated 13F filings for Q4 2019.